Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung Adenocarcinoma

BACKGROUND: Clinical evidence has shown that few non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations can benefit from immunotherapy. The tumor immune microenvironment (TIME) is a significant factor affecting the efficacy of immunotherapy. However, the T...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Teng, Pang, Xiaocong, Wang, Junyun, Wang, Shouzheng, Guo, Yiying, He, Ning, Xing, Puyuan, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200668/
https://www.ncbi.nlm.nih.gov/pubmed/34136375
http://dx.doi.org/10.3389/fonc.2021.591922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200668/
https://www.ncbi.nlm.nih.gov/pubmed/34136375
http://dx.doi.org/10.3389/fonc.2021.591922

Ejemplares similares